Anlon Healthcare IPO Details

Introduction

Anlon Healthcare Limited, a Rajkot-based manufacturer of high-purity pharmaceutical intermediates and active pharmaceutical ingredients (APIs), is launching its public issue as investor interest in health sector IPOs climbs in 2025. The company operates a WHO-GMP and ISO-certified facility and exports to global pharma markets.

Anlon Healthcare IPO is a book build issue of ₹121.03 crores. The issue is entirely a fresh issue of 1.33 crore shares of ₹121.03 crore.

Anlon Healthcare IPO opens for subscription on Aug 26, 2025 and closes on Aug 29, 2025. The allotment for the Anlon Healthcare IPO is expected to be finalized on Sep 1, 2025. Anlon Healthcare IPO will list on BSE, NSE with a tentative listing date fixed as Sep 3, 2025.

Anlon Healthcare IPO price band is set at ₹86.00 to ₹91.00 per share . The lot size for an application is 164. The minimum amount of investment required by an retail is ₹14,104 (164 shares). The lot size investment for sNII is 14 lots (2,296 shares), am

Anlon Healthcare IPO Key Details

Detail	Information
IPO Dates	Aug 26, 2025 – Aug 29, 2025
Issue Size	₹121.03 crore (100% fresh, 1.33 crore shares)
Price Band	₹86 – ₹91 per share
Lot Size	164 shares (min. investment: ₹14,924)
Listing Date	Sep 3, 2025 (BSE & NSE SME segment)
Lead Manager	Interactive Financial Services Ltd. (JM Financial: research/sector commentary)
Registrar	Maashitla Securities Pvt. Ltd.
Face Value	₹10 per share
Issue Type	Book building

Company & Financial Overview

• Business: Manufactures pharmaceutical intermediates and APIs for pharma, nutraceutical, personal care, and animal health sectors.
• Founded: 2013; began manufacturing in 2017
• Certifications: ISO 9001:2015, WHO-GMP, GMP
• Revenue: ₹120.46 crore (FY25, up 81% YoY)
• Net Profit: ₹20.52 crore (FY25; up 112% YoY)
• Assets: ₹181.30 crore (FY25)
• Exports: Multiple countries; 65+ commercial products

Use of Issue Proceeds

• Capital expenditure for expansion
• Repayment/prepayment of loans
• General working capital and corporate purposes

Investor Category	Shares Offered
QIB Shares Offered	Not less than 75% of the Net Issue
Retail Shares Offered	Not more than 10% of the Net Issue
NII Shares Offered	Not Less than 15% of the Net Issue

Company Financials

Anlon Healthcare Ltd.'s revenue increased by 81% and profit after tax (PAT) rose by 112% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	181.30	128.00	111.55
Total Income	120.46	66.69	113.12
Profit After Tax	20.52	9.66	5.82
EBITDA	32.38	15.57	12.66
Net Worth	80.42	21.03	7.37
Reserves and Surplus	40.57	5.03	-4.63
Total Borrowing	58.35	74.56	66.39
Amount in ₹ Crore

JM Financial Services

JM Financial Services, recognized for its investment and market strategy research, has included Anlon Healthcare in its pharmaceuticals sector IPO commentary for 2025. Their analysts highlight the robust growth in API and intermediate manufacturing in India, flagging Anlon’s strong sales and margin growth as a notable point amid sector-wide uptick. You can apply for this IPO through JM Financial Services free demat account.

FAQs

Q1. What is the IPO price band and lot size for Anlon Healthcare?
A: ₹86–₹91 per share; minimum lot size is 164 shares (~₹14,924 minimum investment).

Q2. When does the IPO open and close?
A: Opens August 26, 2025, closes August 29, 2025.

Q3. Where will the shares be listed?
A: BSE and NSE, SME segment; tentative listing on September 3, 2025.

Q4. What are the key business strengths of Anlon Healthcare?
A: Rapid financial growth, diverse high-margin products, strong compliance, and international reach in API/intermediate manufacturing.

Q6. How can retail investors apply?
A: Through JM Financial services free demat account you can apply for this IPO.